[EN] 4-[(3-FLUOROPHENOXY)PHENYLMETHYL]PIPERIDINE METHANESULFONATE: USES, PROCESS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS<br/>[FR] MÉTHANESULFONATE DE 4-[(3-FLUOROPHÉNOXY)PHÉNYLMÉTHYL]PIPÉRIDINE : UTILISATIONS, PROCÉDÉ DE SYNTHÈSE ET COMPOSITIONS PHARMACEUTIQUES
申请人:FAES FARMA SA
公开号:WO2007131846A1
公开(公告)日:2007-11-22
[EN] The present patent application is directed to 4-[(3-fluorophenoxy)phenylmethyl] piperidine methanesulfonic acid salt (formula I), its synthesis and use in the manufacture of a medicament for the treatment and/or prevention of a serotonine and/or norepinephrine mediated disease or condition. The present invention is also directed to pharmaceutical compositions comprising the same. [FR] La présente demande concerne le sel d'acide 4-[(3-fluorophénoxy)phénylméthyl]pipéridine méthanesulfonique (formule I), sa synthèse et son utilisation dans la fabrication d'un médicament pour traiter et/ou pour prévenir une maladie ou une condition à médiation par la sérotonine et/ou norépinéphrine. La présente invention concerne également des compositions pharmaceutiques comprenant ledit sel.
4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
申请人:FAES FARMA, S.A.
公开号:EP1854785A1
公开(公告)日:2007-11-14
The present patent application is directed to 4-[(3-fluorophenoxy)phenylmethyl] piperidine methanesulfonic acid salt (formula I), its synthesis and use in the manufacture of a medicament for the treatment and/or prevention of a serotonine and/or norepinephrine mediated disease or condition. The present invention is also directed to pharmaceutical compositions comprising the same.
4-[(3-FLUOROPHENOXY)PHENYLMETHYL]PIPERIDINE METHANESULFONATE: USES, PROCESS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS
申请人:Orjales Venero Aurelio
公开号:US20100004283A1
公开(公告)日:2010-01-07
The present patent application is directed to 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonic acid salt (formula I), its synthesis and use in the manufacture of a medicament for the treatment and/or prevention of a serotonine and/or norepinephrine mediated disease or condition. The present invention is also directed to pharmaceutical compositions comprising the same.